Agency Emergency Information Collection Clearance Request for Public Comment
| Published date | 27 May 2021 |
| Citation | 86 FR 28633 |
| Record Number | 2021-11255 |
| Section | Notices |
| Court | National Institutes Of Health |
Federal Register, Volume 86 Issue 101 (Thursday, May 27, 2021)
[Federal Register Volume 86, Number 101 (Thursday, May 27, 2021)]
[Notices]
[Pages 28633-28634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11255]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Agency Emergency Information Collection Clearance Request for
Public Comment
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide opportunity for public comment on proposed data
collection projects, the National Institutes of Health (NIH) will
publish periodic summaries of propose projects to be submitted to the
Office of Management and Budget (OMB) for review and approval.
DATES: Comments on the information collection request must be received
on or before 10 days of this published notice.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted within 10 days. You may send your
comments electronically to http://www.regulations.gov. Follow the
instructions for ``Comment or Submission'' or ``More Search Options''
to find the information collection document(s) that are accepting
comments.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection
[[Page 28634]]
plans and instruments, submit comments in writing, or request more
information on the proposed project, contact: Ms. Mikia P. Currie,
Office of Policy for Extramural Research Administration, 6705 Rockledge
Drive, Suite 350, Bethesda, Maryland 20892, or call a non-toll-free
number 301-435-0941 or Email your request, including your address to
[email protected]. Formal requests for additional
plans and instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) The necessity and utility of the
proposed information collection for the proper performance of the
agency's functions; (2) the accuracy of the estimated burden; (3) ways
to enhance the quality, utility, and clarity of the information to be
collected; and (4) the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
Title of the Collection: Audience Feedback to Inform Ongoing
Messaging and Strategies for ``Combat COVID''
Type of Collection: Emergency.
OMB No. 0925-NEW--Federal COVID Response
Abstract: The Federal COVID Response (FCR) Team is a cross-agency
partnership that includes the U.S. Department of Health and Human
Services (HHS), including the National Institutes of Health (NIH)
Office of the Director, Centers for Disease Control and Prevention
(CDC), the U.S. Food and Drug Administration (FDA), the Biomedical
Advanced Research and Development Authority (BARDA), and the U.S.
Department of Defense (DOD). The FCR Team oversees the ``Combat COVID''
initiative--a multifaceted effort to provide the general public and
healthcare providers with the latest evidence-based information on
COVID-19 treatments and the Accelerating COVID-19 Therapeutic
Interventions and Vaccines (ACTIV) clinical trials (including the
combatcovid.hhs.gov website). The NIH is especially interested in
recruiting participants from groups who have historically been
underrepresented in clinical trials. Together with their contractor,
the FCR Team is working to:
Address participation barriers and raise awareness of
ACTIV clinical trials, and
Ensure the general public's and health care provider's
needs are met as it pertains to evidence-based information on these
trials.
The purpose of the information collection is to collect routine
feedback from the Combat COVID Initiative's two target audiences (the
general public and healthcare providers) to identify evolving needs and
better disseminate relevant information relates to COVID-19 treatment
and ACTIV clinical trial resources. Because the COVID-19 treatment
landscape continues to evolve and audience needs continue to change, it
is critical for the FCR Team to collect routine feedback from the
general public (especially from groups who have not historically been
well-represented in clinical trials) and healthcare providers to
identify these evolving needs. By understanding evolving needs, the FCR
team will be able to properly develop and broadly disseminate relevant
COVID-19 treatment and ACTIV clinical trial resources. This effort will
require ongoing data collection over the next 20 months (through the
end of December 2022).
Data collected through this effort will be used to inform the
development and broad dissemination of Combat COVID resources,
including new or enhanced messages, materials and/or web pages
(combatcovid.hhs.gov).
The team will employ two strategies to collect this routine
audience feedback:
1. DATA COLLECTION STRATEGY 1: Monthly 60-minute virtual audience
feedback teams sessions (focus groups, in-depth interviews, online
bulletin boards) for rapid testing of new Combat COVID messages,
concepts, ideas, resources, web pages, and materials.
2. DATA COLLECTION STRATEGY 2: 15-minute custom web surveys to
understand target audiences' needs and awareness of Combat COVID over
time, and to inform ongoing messages and strategies.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Consumer Audience Feedback Team Screener 120 1 5/60 10
(Attachment 1).................................
HCP Audience Feedback Team Screener (Attachment 40 1 5/60 3
2).............................................
Consumer Audience Feedback Activity (Attachments 60 12 1 720
3 & 5).........................................
HCP Audience Feedback Activity (Attachments 4 & 20 12 1 240
5).............................................
Benchmark & Follow-Up Web Surveys--Consumer 2,000 5 15/60 2,500
Audience (Attachment 6)........................
Benchmark & Follow-Up Web Survey--HCP Audience 300 5 15/60 375
(Attachment 6).................................
---------------------------------------------------------------
Total....................................... 2,540 12,620 .............. 3848
----------------------------------------------------------------------------------------------------------------
Dated: May 20, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-11255 Filed 5-26-21; 8:45 am]
BILLING CODE 4140-01-P
